1. Home
  2. KRON vs CASI Comparison

KRON vs CASI Comparison

Compare KRON & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRON
  • CASI
  • Stock Information
  • Founded
  • KRON 2017
  • CASI 1991
  • Country
  • KRON United States
  • CASI China
  • Employees
  • KRON N/A
  • CASI N/A
  • Industry
  • KRON Medicinal Chemicals and Botanical Products
  • CASI Biotechnology: Pharmaceutical Preparations
  • Sector
  • KRON Health Care
  • CASI Health Care
  • Exchange
  • KRON Nasdaq
  • CASI Nasdaq
  • Market Cap
  • KRON 59.1M
  • CASI 58.8M
  • IPO Year
  • KRON 2020
  • CASI 1996
  • Fundamental
  • Price
  • KRON $0.99
  • CASI $2.62
  • Analyst Decision
  • KRON Buy
  • CASI Strong Buy
  • Analyst Count
  • KRON 3
  • CASI 1
  • Target Price
  • KRON $1.63
  • CASI $6.00
  • AVG Volume (30 Days)
  • KRON 292.4K
  • CASI 42.2K
  • Earning Date
  • KRON 11-13-2024
  • CASI 11-15-2024
  • Dividend Yield
  • KRON N/A
  • CASI N/A
  • EPS Growth
  • KRON N/A
  • CASI N/A
  • EPS
  • KRON N/A
  • CASI N/A
  • Revenue
  • KRON $9,864,000.00
  • CASI $22,055,000.00
  • Revenue This Year
  • KRON $62.21
  • CASI N/A
  • Revenue Next Year
  • KRON N/A
  • CASI $134.79
  • P/E Ratio
  • KRON N/A
  • CASI N/A
  • Revenue Growth
  • KRON 146.48
  • CASI N/A
  • 52 Week Low
  • KRON $0.69
  • CASI $2.05
  • 52 Week High
  • KRON $1.60
  • CASI $8.19
  • Technical
  • Relative Strength Index (RSI)
  • KRON 53.69
  • CASI 38.56
  • Support Level
  • KRON $0.92
  • CASI $2.44
  • Resistance Level
  • KRON $1.02
  • CASI $2.76
  • Average True Range (ATR)
  • KRON 0.05
  • CASI 0.29
  • MACD
  • KRON 0.00
  • CASI 0.03
  • Stochastic Oscillator
  • KRON 77.38
  • CASI 21.18

About KRON Kronos Bio Inc.

Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine plan by targeting dysregulated transcription. The company operates in one business segment, the development of biopharmaceutical products.

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

Share on Social Networks: